IRIS
DELLA TORRE, EMANUEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.867
AS - Asia 4.332
NA - Nord America 3.048
SA - Sud America 1.138
AF - Africa 96
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.523
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.868
RU - Federazione Russa 2.520
SG - Singapore 1.446
CN - Cina 1.437
IT - Italia 947
BR - Brasile 926
HK - Hong Kong 529
SE - Svezia 517
VN - Vietnam 434
FR - Francia 215
DE - Germania 166
GB - Regno Unito 133
BD - Bangladesh 113
FI - Finlandia 94
CA - Canada 80
AR - Argentina 75
IN - India 71
MX - Messico 59
NL - Olanda 58
ID - Indonesia 41
ES - Italia 40
JP - Giappone 39
AT - Austria 37
PL - Polonia 37
TR - Turchia 37
ZA - Sudafrica 35
AU - Australia 33
IQ - Iraq 32
EC - Ecuador 31
CO - Colombia 26
PY - Paraguay 25
PK - Pakistan 22
IE - Irlanda 19
UA - Ucraina 19
CL - Cile 16
MY - Malesia 16
PE - Perù 16
VE - Venezuela 16
MA - Marocco 14
EG - Egitto 13
PH - Filippine 11
SA - Arabia Saudita 11
TN - Tunisia 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
IR - Iran 10
BE - Belgio 9
HN - Honduras 9
JO - Giordania 9
KE - Kenya 9
LT - Lituania 9
CH - Svizzera 8
JM - Giamaica 8
NP - Nepal 7
NZ - Nuova Zelanda 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
GT - Guatemala 6
HU - Ungheria 6
KZ - Kazakistan 5
RO - Romania 5
AL - Albania 4
CY - Cipro 4
LB - Libano 4
LV - Lettonia 4
NI - Nicaragua 4
PT - Portogallo 4
TH - Thailandia 4
UY - Uruguay 4
BH - Bahrain 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
GR - Grecia 3
KR - Corea 3
MD - Moldavia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BO - Bolivia 2
CG - Congo 2
EU - Europa 2
HR - Croazia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
Totale 13.517
Salva come PNG Salva come JPEG
Città #
Singapore 611
Moscow 526
Hong Kong 524
Dallas 454
Ashburn 365
Shanghai 323
San Jose 310
Beijing 263
Hefei 199
New York 191
Lawrence 183
Princeton 183
Lauterbourg 179
Milan 169
Ho Chi Minh City 154
Hanoi 95
São Paulo 88
Helsinki 78
Los Angeles 77
Rome 71
Boardman 52
Santa Clara 48
Munich 45
Rio de Janeiro 35
Orem 33
Nuremberg 32
Warsaw 32
London 30
Denver 29
Montreal 25
Tokyo 25
Belo Horizonte 24
Atlanta 22
Seattle 22
Guangzhou 21
Poplar 21
Turin 21
Brooklyn 20
Mexico City 20
Dublin 19
Frankfurt am Main 19
Phoenix 19
Toronto 19
Chennai 18
Cagliari 17
Bologna 16
Council Bluffs 16
Da Nang 16
Haiphong 16
Naples 16
Vienna 16
Houston 15
Stockholm 15
Baghdad 14
Boston 14
Brasília 14
Cesano Boscone 14
Florence 14
Genoa 14
Johannesburg 14
Ankara 13
Manaus 13
Amsterdam 12
Mapello 12
Quito 12
Bari 11
Kuala Lumpur 11
Pescara 11
Porto Alegre 11
San Francisco 11
Turku 11
Biên Hòa 10
Curitiba 10
Guarulhos 10
Pavia 10
Rovigo 10
Tashkent 10
Wollongong 10
Xi'an 10
Asunción 9
Bergamo 9
Cape Town 9
Galliate 9
Guayaquil 9
Jakarta 9
Jiaxing 9
Melbourne 9
Nairobi 9
Pune 9
Salvador 9
Amman 8
Barnet 8
Basingstoke 8
Brisbane 8
Campinas 8
Chicago 8
Falkenstein 8
Istanbul 8
Manchester 8
Mumbai 8
Totale 6.322
Salva come PNG Salva come JPEG
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 373
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 250
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 209
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 171
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 170
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 161
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 152
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 147
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 139
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 135
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 131
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 128
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 125
IgG4-Related Midline Destructive Lesion: Expanding the spectrum of organ involvement in IgG4-related disease 121
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 118
Urgent manifestations of immunoglobulin G4-related disease 115
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 115
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 113
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 111
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 110
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 107
Advances in the diagnosis and management of IgG4 related disease. 107
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 105
Analisi delle sottopopolazioni T linfocitarie su sangue periferico dei pazienti affetti da malattia IgG4 correlata: aspetti patogenetici e risposta alla terapia con rituximab 105
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 103
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 102
IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. 99
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 99
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 97
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 97
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 95
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 94
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 94
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 93
ALLERGIC PROFILE AND ALLERGENSPECIFIC IMMUNOTHERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A SINGLE CENTER OBSERVATIONAL STUDY 93
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 92
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 92
ANTIAPOPTOTIC AND IMMUNOMODULATORY EFFECTS OF INTERLEUKIN 7 IN AN EX VIVO MODEL OF HUMAN LYMPHOID TISSUE 92
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 88
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 88
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 88
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 88
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 87
"How I manage" IgG4-Related Disease 87
Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case 87
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 85
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 85
B cells orchestrate tissue fibrosis in IgG4-Related Disease 85
Lymphadenopathy in the rheumatology practice: a pragmatic approach 84
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 83
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 82
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 81
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 81
25. Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study. 80
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 79
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 78
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 78
Atopia e malattia IgG4-correlata: relazione casuale o causale? 78
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 77
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 77
Artrite reumatoide. Dottore mi spieghi meglio 76
Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation 75
Salivary Gland Disease in IgG4-Related Disease is Associated with Allergic Conditions 75
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION 74
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 74
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 73
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 71
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 71
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 70
EFFICACY OF LONG-TERM TREATMENT WITH BIOLOGIC AGENTS IN REFRACTORY ADULT ONSET STILL’S DISEASE: A SINGLE CENTRE EXPERIENCE ON 16 PATIENTS 70
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang 69
Systemic lupus erythematosus and COVID-19: what we know so far 69
CLONAL EXPANSION OF CD4+ CYTOTOXIC T LYMPHOCYTES IN IGG4-RELATED DISEASE 69
IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. 69
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 69
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED AUTOIMMUNE PANCREATITIS 68
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 67
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 67
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 67
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 66
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 64
EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study 64
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 63
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 62
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 62
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma 61
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 61
IgG4-Related diseases 61
Malattia sistemica e colangiopatia IgG4-relata 61
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 61
COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients 59
B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. 59
Malattie autoinfiammatorie e altre malattie immunomediate a patogenesi incerta 59
Palate perforation differentiates cocaine-induced midline destructive lesions from granulomatosis with polyangiitis 58
Immunology of IgG4-related disease 58
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 58
CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. 58
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 57
Clonal Expansion of a Speci c Subset of Cytotoxic CD4+T Cells and Tissue Apoptosis in Patients with IgG4-related Disease 57
Side effects from polydioxanone 57
Totale 9.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022348 1 0 151 33 6 22 14 23 34 21 23 20
2022/20231.129 455 213 66 8 32 115 62 57 59 14 22 26
2023/2024920 30 62 81 82 49 167 42 89 5 42 92 179
2024/20252.858 351 84 81 76 97 222 352 300 550 329 177 239
2025/20268.382 631 790 689 1.061 631 258 680 560 2.181 446 261 194
2026/2027110 110 0 0 0 0 0 0 0 0 0 0 0
Totale 13.796